Showing 701-710 of 855 results for "".
- And The Winner Is... Algeness Named Top Finalist in Terra2 Solution Skin Health Innovation Competitionhttps://modernaesthetics.com/news/and-the-winner-is-algeness-named-top-finalist-in-terra2-solution-skin-health-innovation-competition/2473067/Advanced Aesthetic Technologies, Inc. (AAT) and Algeness are finalists in the recent Terra2 Solutions Skin Health Innovation Competition. Algeness is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural and based on purified agarose with
- Pre-clinical Data Suggest Soliton's RAP Technology Can Help Liver Fibrosishttps://modernaesthetics.com/news/pre-clinical-data-suggest-solitons-rap-technology-can-help-liver-fibrosis/2473066/A pre-clinical study in animals demonstrates positive results for Soliton’s RAP device as a potential treatment for liver fibrosis. Validated laboratory and histological assessments in a mouse model demonstrated that Rapid Acoustic Pulse (RAP) therapy reduced the effects of induced liver fi
- Introducing the Cutaneous Procedures Adverse Events Reporting (CAPER) Systemhttps://modernaesthetics.com/news/introducing-the-cutaneous-procedures-adverse-events-reporting-caper-system/2473065/The American Society for Dermatologic Surgery Association (ASDSA) and the Northwestern University Department of Dermatology are launching the Cutaneous Procedures Adverse Events Reporting (CAPER) system. This voluntary reporting system gathers patients’ adverse events (AEs) encoun
- Industry Responds to COVID-19: Biopelle, Galderma US Aestheticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-biopelle-galderma-us-aesthetics/2473063/Biopelle One bright spot for many aesthetic practices during the COVID-19 pandemic has been persistent and perhaps increased demand for skincare. Biopelle has responded to support physicians who wish to dispense their products. “We offer a ski
- Soliton Receives Best New Technology Awardhttps://modernaesthetics.com/news/soliton-named-best-new-technology/2473062/Soliton's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA). The Soliton RAP device, which uses proprietary design acoustic shockwaves to mechanically disrupt targeted cellular structures in a completely
- ASDS Issues New Recommendations on Preventing and Treating Filler Complicationshttps://modernaesthetics.com/news/asds-issues-new-recommendations-on-preventing-and-treating-filler-complications/2473060/The American Society for Dermatologic Surgery (ASDS) Multispecialty Soft-tissue Fillers Guideline Task Force has
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- Business News: Dominion Aesthetic Technologies Closes $23.7 Million Series B Financinghttps://modernaesthetics.com/news/business-news-dominion-aesthetic-technologies-closes-237-million-series-b-financing/2473052/Dominion Aesthetic Technologies, developers of EON, closed Series B financing, raising a total of $23.7 million. The series B funding will accelerate the manufacturing and commercialization of EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasi
- Fat Loss Accelerates Facial Aging, Not Gravityhttps://modernaesthetics.com/news/fat-loss-accelerates-facial-aging-not-gravity/2473051/The real culprit behind facial aging may be the loss of fat both near the surface of the skin and in deeper areas, not gravity or sagging, finds a
- Pulse Biosciences Receives European Clearance for CellFX Systemhttps://modernaesthetics.com/news/pulse-biosciences-receives-european-clearance-for-cellfx-system/2473050/Pulse Biosciences, Inc. will proceed with its planned controlled launch of the CellFX System to medical practices within the European Union (EU), now that it has received CE mark for the system. The European clearance is for the treatment of general dermatologic conditions, includi